zł710.00
0.28%
Warsaw, Oct 01, 04:42 pm CEST. Closed.
ISIN
PLTRFRM00018
Symbol
NEU

Neuca Stock price

zł714.00
-62.00 7.99% 1M
+61.59 9.44% 6M
-79.82 10.06% YTD
+47.93 7.20% 1Y
+91.48 14.69% 3Y
-104.57 12.78% 5Y
+398.35 126.20% 10Y
+672.00 1,599.83% 20Y
Warsaw, Closing price Thu, Oct 01 2026
+6.00 0.85%
ISIN
PLTRFRM00018
Symbol
NEU

Is Neuca a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
zł3.3b
Enterprise Value
zł4.0b
Net debt
zł664.9m
Cash
zł137.3m
Shares outstanding
4.5m
Valuation (TTM | estimate)
P/E
16.8
P/S
0.2 | 0.2
EV/Sales
0.3 | 0.3
EV/FCF
14.6
P/B
2.9
Dividends
DPS
zł17.80
Yield 1Y | 5Y
2.5% | 2.0%
Growth 1Y | 5Y
11.3% | 12.2%
Payout 1Y | 3Y
52.3% | 48.0%
Increased
20 Years
Financials (TTM | estimate)
Revenue
zł14.1b | zł14.6b
EBITDA
zł425.1m
EBIT
zł295.2m
Net Income
zł196.5m
Free Cash Flow
zł270.6m
Growth (TTM | estimate)
Revenue
8.4% | 6.7%
EBITDA
14.1%
EBIT
18.6%
Net Income
45.1%
Free Cash Flow
130.1%
Margin
Gross
11.6%
EBITDA
3.0%
EBIT
2.1%
Net
1.4%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
16.9%
Return on Equity
14.7%
ROCE
18.4%
ROIC
11.3%
Debt/Equity
0.7
More
EPS
zł42.1
FCF per Share
zł60.1
Short interest
-
Employees
5k
Rev per Employee
zł2.6m

Neuca Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Neuca forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Neuca forecast:

Buy
88%
Hold
13%

Financial data from Neuca

Jun '26
+/-
%
14,138 14,138
8% 8%
100%
- Direct Costs 12,495 12,495
8% 8%
88%
1,643 1,643
10% 10%
12%
- Selling and Administrative Expenses 1,341 1,341
9% 9%
9%
- Research and Development Expense - -
-
-
425 425
14% 14%
3%
- Depreciation and Amortization 130 130
5% 5%
1%
EBIT (Operating Income) EBIT 295 295
19% 19%
2%
Net Profit 197 197
45% 45%
1%

In millions PLN.

Don't miss a Thing! We will send you all news about Neuca directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

NEUCA SA engages in the wholesale of pharmaceutical products. It operates through the following segments: Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials, and Telemedicine. The Pharmaceutical Wholesale segment provides medical products for pharmacies. The Own Brands segment comprises market launching of pharmaceutical products under own brand. The Outpatient Care Clinics, Clinical Trials, and Telemedicine segment activities include general medical practice, clinical trials, and telemedicine. The company was founded by Kazimierz Michal Herba in 1990 and is headquartered in Torun, Poland.

Head office Poland
CEO Piotr Sucharski
Employees 5,172
Founded 1990
Website www.neuca.pl

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today